Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/05/286   
Active ingredient: N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole
Indication: Treatment of multiple myeloma
Sponsor: Dr Geoffrey Allan
Flat 1a, 11 Chelsea Embankment, London, SW3 4LE, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2005 Orphan designation EMEA/OD/012/05 (2005)1906 of 20/06/2005